1933 Industries Inc.
1933 Industries Inc.
- Market cap
- $3.97M
- P/E ratio
- 6.25
Your view on TGIFF
Overview
What the company does, where it operates, and who runs it.
About 1933 Industries Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brian Farrell
- Headquarters
- 1055 West Hastings Street, Vancouver, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brian Farrell
- Headquarters
- 1055 West Hastings Street, Vancouver, BC, CA
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in the medical and recreational cannabis sectors.
The company also offers cannabidiol (CBD) infused products, such as vape pens, cartridges, lotions, lip balms, hemp seed oils, edible products, topical and dietary supplements, cosmetics, tinctures, sauces, vaporizers, drink additives, baking items, sweeteners, capsules, and tetrahydrocannabinol concentrates under the Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands.
In addition, it provides cannabis flowers and concentrates. 1933 Industries Inc. offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for 1933 Industries Inc.. Starting points for 1933 Industries Inc.: P/E 6.3, beta 1.84 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for 1933 Industries Inc.. 1933 Industries Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for 1933 Industries Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJul 2026 | Next quarterOct 2026 | This yearYear to Jul 2026 | Next yearYear to Jul 2027 |
|---|---|---|---|---|
| Average estimate | −CAD 0.01 | −CAD 0.01 | −CAD 0.05 | −CAD 0.05 |
| Lowest estimate | −CAD 0.01 | −CAD 0.01 | −CAD 0.05 | −CAD 0.05 |
| Highest estimate | −CAD 0.01 | −CAD 0.01 | −CAD 0.05 | −CAD 0.05 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | CAD 0.001 | CAD 0.001 | CAD 0.001 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterJul 2026 | Next quarterOct 2026 | This yearYear to Jul 2026 | Next yearYear to Jul 2027 |
|---|---|---|---|---|
| Average estimate | CAD 5.60M | CAD 6.36M | CAD 19.24M | CAD 19.15M |
| Lowest estimate | CAD 5.60M | CAD 6.36M | CAD 19.24M | CAD 19.15M |
| Highest estimate | CAD 5.60M | CAD 6.36M | CAD 19.24M | CAD 19.15M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | CAD 3.11M | CAD 3.97M | CAD 12.59M | — |
| Growth vs a year ago | +80.1% | +60.4% | +52.8% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for 1933 Industries Inc.. 1933 Industries Inc. has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AVTBFAvant Brands Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $6.9M | ||
| CANNTrees Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | $4.1M | ||
| CLABFCore One Labs Inc. | Healthcare | Medical - Pharmaceuticals | $500 | ||
| CNGGFCann Group Limited | Healthcare | Drug Manufacturers - Specialty & Generic | $4.4M | ||
| CPIVFCaptiva Verde Wellness Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | $7.5M | ||
| LIFDLFTD Partners Inc. | Consumer Defensive | Tobacco | $2.8M | ||
| RVVTFRevive Therapeutics Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | $3.8M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| LABS.TOMediPharm Labs Corp. | Healthcare | TSX | $25.6M | ||
| LEEEFLeef Brands Inc. | Healthcare | OTC | $25.6M | ||
| LEEF.CNLeef Brands Inc. | Healthcare | CNQ | $38.1M | ||
| LFCRLifecore Biomedical, Inc. | Healthcare | NASDAQ | $242.2M | ||
| LGP.AXLittle Green Pharma Ltd | Healthcare | ASX | — | ||
| LITHBioELife Corp. | Healthcare | OTC | — | ||
| LMLLFPharmadrug Inc. | Healthcare | OTC | $746,817 | ||
| LNTHLantheus Holdings, Inc. | Healthcare | NASDAQ | $6.7B | ||
| LOVE.TOCannara Biotech Inc. | Healthcare | TSX | $198.6M | ||
| LOVFFCannara Biotech Inc. | Healthcare | OTC | $125.5M | ||
| LOWLFLowell Farms Inc. | Healthcare | OTC | $1,815 | ||
| LTHOLegacy Technology Holdings, Inc. | Healthcare | OTC | $1,720 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of 1933 Industries Inc.